FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity

AIMS: The clinical use of doxorubicin for the treatment of cancer is limited by its cardiotoxicity. Flavaglines are natural products that have both potent anticancer and cardioprotective properties. A synthetic analog of flavaglines, FL3, efficiently protects mice from the cardiotoxicity of doxorubi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Qureshi, Rehana, Yildirim, Onur, Gasser, Adeline, Basmadjian, Christine, Zhao, Qian, Wilmet, Jean-Philippe, Désaubry, Laurent, Nebigil, Canan G.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2015
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4633129/
https://ncbi.nlm.nih.gov/pubmed/26536361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0141826
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki